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S

ince 1884 when the School of Veterinary
Medicine was established by the University
of Pennsylvania’s School of Medicine, we
have firmly believed in the concept of “One
Medicine”—that human medicine and
veterinary medicine are inextricably linked. As we celebrate
our 125th anniversary we can look back and see clearly
the tremendous contributions our faculty, staff and alumni
have made in bettering the health of animals. Along the
way, we have also consistently pursued the One Medicine
concept so that what we learn about animal health helps us
understand human disease.

Man’s Best Friend
One area where veterinary medicine is significantly
effecting change is promoting the study of spontaneously
occurring diseases in large animals to further the
understanding of disease models. Primates, cattle, horses,
cats and dogs have all contributed to our knowledge of
health, yet for a very long time, mice were king. Although
mouse models have many benefits, including low cost and
short time to maturity, they also have significant limitations
such as their clinical similarities both genetically and
physically to humans making translational and pre-clinical
studies less than ideal.
Research focusing on canine models of disease, in
particular, is gaining momentum and for very good
reasons. Studying pure breed dogs, due to the very nature
of selective breeding and closed gene pools, presents
extraordinary opportunity to identify potential links to
genetics. Nearly half of genetic diseases reported in dogs
occur predominantly, or exclusively, in one or a few
breeds. Access to pedigrees simplifies following disease
from one generation to the next.
Dogs have more naturally occurring inherited diseases
than any other species except man. Nearly half of these
diseases are common to humans. The top 10 diseases
of greatest concern to dogs include cancer, epilepsy,
autoimmune diseases, heart disease and diseases causing
cataracts. Between humans and dogs, naturally occurring
diseases tend to be similar biologically and histologically in
their clinical course. Since humans and their dogs share a

From the Bench to the Bedside
Translational medicine refers to taking discoveries made in
basic science research labs and using them to very quickly
develop therapies useful for treating patients—whether
they are humans or animals. The goal of translational
medicine is to accelerate the application of basic
discoveries to clinical practice, including diagnosis and
treatment of human and veterinary patients. But it is not as
easy as one might think.
It is estimated that 80 percent of novel cancer drugs are
never used because they fail during clinical trials. Failure
is costly and time consuming. It is no wonder clinical
trials testing new treatments and therapies are expanding
and moving into the veterinary clinic as awareness of the
potential of studies involving canine models continues
to rise. Veterinary medicine and our canine friends are
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common environment there is tremendous opportunity
to explore significant relevance among environmental
factors.
Many researchers believe cancer is the area of health
where dogs may have greatest impact in accelerating our
understanding and advancing therapeutics. Cancer is the
most frequent canine disease, and cancer is the largest
killer of dogs over age two. Since humans and dogs
share similar bone cancers, skin cancers and lymphomas,
comparative research between humans and canines holds
tremendous potential for furthering our understanding of
cancer-related disease, both in humans and in animals.
Certain breeds of dog are known to develop
certain types of cancer. Osteosarcoma (bone cancer),
for example, is common in the Greyhound and the
Rottweiler. It is also the sixth most common cancer seen
in children.
Our canine friends can teach us much about the
natural progression of tumors. Research suggests that in
the mechanism of tumor development there are more
similarities between humans and dogs than between
humans and any other model organism.
Clinical intervention can be easily studied over a
condensed period of time due to the shorter life span of
dogs. Survival rates for dogs suffering from cancer are
detailed over a period of one year as opposed to five
in human oncology. Clinical trials looking at disease
progression tend to achieve fairly rapid results.
Due to similarities in the physiology of canines and
humans, dogs metabolize and respond to drugs in ways
very similar to humans. When diseases occur, dogs
provide invaluable information to us as we move from
the laboratory to veterinary and human clinics.

being acknowledged for the tremendous potential that
comparative medical models have in understanding disease
and efficiently and more quickly bringing new treatments
to your veterinary clinic as well as your doctor’s office.
Penn, in both its schools of Medicine and Veterinary
Medicine, has made significant advances in bringing
together basic science researchers and clinicians. Those
who treat patients on a regular basis and those who focus
primarily on laboratory research have operated for years
within very different cultures. However, the determination
to harness the potential of translational medicine has lead
to new collaboration, innovation and commitment to
advancing practical clinical solutions, developing better
products and improving care. One Medicine—for humans
and animals—may have seemed far-fetched just a short
time ago, but thanks to our animal friends, particularly our
canine friends, not for much longer.
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